Search results
Showing 8176 to 8190 of 8904 results
Repotrectinib for treating ROS1-positive advanced non-small-cell lung cancer [ID6277]
Discontinued Reference number: GID-TA11302
Discontinued Reference number: GID-TA11007
Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223
Discontinued Reference number: GID-HST10019
Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]
Discontinued Reference number: GID-HST10038
Eteplirsen for treating Duchenne muscular dystrophy [ID1003]
Discontinued Reference number: GID-HST10007
Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]
Discontinued Reference number: GID-HST10004
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]
In development Reference number: GID-HST10037 Expected publication date: TBC
Discontinued Reference number: GID-MT117
Discontinued Reference number: GID-MT163
Discontinued Reference number: GID-MT130
This guidance has been updated and replaced by NICE guideline NG220.
This guideline has been updated and replaced by NICE guideline NG246.
This guideline has been updated and replaced by the NICE guideline on intrapartum care (NG235).
This guideline has been updated and replaced by NICE's guideline on pneumonia: diagnosis and management (NG250).
November 2025: We have withdrawn this quality standard following the launch of new NICE guidelines on suspected sepsis in people aged 16 or over, suspected sepsis in under 16s and suspected sepsis in pregnant or recently pregnant people. This quality standard is now partially replaced by NICE's quality standard on suspected sepsis in over 16s. Quality standards for sepsis in people under 16 and for people who are or have recently been pregnant will publish when paediatric and maternity early warning score tools are reviewed for the next update to the NICE guidelines in 2026. For any queries, please contact qualitystandards@nice.org.uk.